Development of thiazole-hydrazone hybrids for targeted therapy of non-small cell lung cancer.
Flow cytometry analyses revealed that these agents induced apoptosis and G0/G1 cell cycle arrest, indicating that their cytotoxic effects are mediated through these mechanisms, highlighting the potential of thiazolyl hydrazones as targeted therapeutic agents, warranting further investigations for NSCLC treatment.